NASDAQ:SGRYSurgery Partners Stock Price, Forecast & News

Surgery Partners' stock was trading at $8.86 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SGRY shares have increased by 54.4% and is now trading at $13.68. View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Surgery Partners.

Surgery Partners is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Surgery Partners.

Surgery Partners Inc (NASDAQ:SGRY) posted its quarterly earnings data on Monday, May, 11th. The company reported ($0.34) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.62) by $0.28. The company earned $441 million during the quarter, compared to analyst estimates of $377.50 million. Surgery Partners had a negative net margin of 4.38% and a negative return on equity of 2.21%. View Surgery Partners' earnings history.

4 brokers have issued twelve-month price objectives for Surgery Partners' shares. Their forecasts range from $14.00 to $19.00. On average, they anticipate Surgery Partners' stock price to reach $15.50 in the next twelve months. This suggests a possible upside of 13.3% from the stock's current price. View analysts' price targets for Surgery Partners.

Press coverage about SGRY stock has trended somewhat positive this week, InfoTrie Sentiment reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Surgery Partners earned a news sentiment score of 1.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the stock's share price in the immediate future. View the latest news aboutSurgery Partners.

Surgery Partners saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 2,960,000 shares, an increase of 6.9% from the April 30th total of 2,770,000 shares. Based on an average daily trading volume, of 981,200 shares, the short-interest ratio is presently 3.0 days. Currently, 12.9% of the company's stock are sold short. View Surgery Partners' Current Options Chain.

Some companies that are related to Surgery Partners include NeoGenomics (NEO), Option Care Health (OPCH), Novavax (NVAX), Insmed (INSM), Alector (ALEC), Taro Pharmaceutical Industries (TARO), Integer (ITGR), LivaNova (LIVN), Alkermes (ALKS), Amarin (AMRN), Apellis Pharmaceuticals (APLS), Acadia Healthcare (ACHC), ADC Therapeutics (ADCT), Merit Medical Systems (MMSI) and Turning Point Therapeutics (TPTX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Verizon Communications (VZ), Allena Pharmaceuticals (ALNA), Bank of America (BAC), Netflix (NFLX), NVIDIA (NVDA), Ring Energy (REI), Ring Energy (REI), Advanced Micro Devices (AMD), Alteryx (AYX) and Carnival (CCL).

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Surgery Partners' stock is owned by many different retail and institutional investors. Top institutional shareholders include Clearbridge Investments LLC (6.98%), BlackRock Inc. (3.29%), Centerbridge Partners L.P. (2.05%), JPMorgan Chase & Co. (1.62%), State Street Corp (0.92%) and Nuveen Asset Management LLC (0.46%). Company insiders that own Surgery Partners stock include Adam T Feinstein, Brandan Lingle, Jason Eric Evans and Teresa Deluca. View institutional ownership trends for Surgery Partners.

SGRY stock was sold by a variety of institutional investors in the last quarter, including Pictet Asset Management Ltd., BlackRock Inc., Invesco Ltd., Clearbridge Investments LLC, Eaton Vance Management, State Street Corp, UBS Group AG, and Parametric Portfolio Associates LLC. View insider buying and selling activity for Surgery Partners.

SGRY stock was acquired by a variety of institutional investors in the last quarter, including Centerbridge Partners L.P., JPMorgan Chase & Co., Assenagon Asset Management S.A., Voce Capital Management LLC, Nuveen Asset Management LLC, Two Sigma Investments LP, Victory Capital Management Inc., and Victory Capital Management Inc.. Company insiders that have bought Surgery Partners stock in the last two years include Jason Eric Evans, and Teresa Deluca. View insider buying and selling activity for Surgery Partners.

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SGRY stock can currently be purchased for approximately $13.68.

Surgery Partners has a market capitalization of $691.09 million and generates $1.83 billion in revenue each year. The company earns $-74,800,000.00 in net income (profit) each year or ($1.10) on an earnings per share basis. Surgery Partners employs 9,600 workers across the globe.

The official website for Surgery Partners is www.surgerypartners.com.

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]